Back to AL Alphabet Inc.
LYEL5 quarters
Position history for ALAlphabet Inc.'s holdings in LYELL IMMUNOPHARMA INC
Yes. Alphabet holds 293,256 shares of LYEL (Lyell Immunopharma), worth $4.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Alphabet has held LYEL in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$4.1M
Current Shares
293,256
Total Value Change
+$1.5M
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.